Chimeric Clotting Factors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130216513A1
SERIAL NO

13809289

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Chimeric clotting factors which localize the therapeutic to sites of coagulation (e.g., by being targeted to platelets or being activatable at sites of coagulation), have reduced clearance rates, have improved manufacturability, have reduced thrombogenicity, have enhanced activity, or have more than one of these characteristics are described as are methods for making chimeric clotting factors and methods for improving hemostasia using these clotting factors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOVERATIV THERAPEUTICS INC225 SECOND AVENUE WALTHAM MA 02451

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bitonti, Alan Acton, US 3 15
Peters, Robert West Roxbury, US 95 1167
Salas, Joe Wayland, US 21 101

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation